Serologicals Corporation (NASDAQ: SERO) announced today that Chemicon International, Inc., its wholly-owned subsidiary, and Stem Cell Sciences plc (LSE:STEM, SCS) are launching the ESGRO Complete(TM) product line for murine embryonic stem (ES) cell culture, following the establishment of an exclusive agreement on November 3, 2005.
